- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2524-4426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Developing preclinical models of neuroblastoma: driving therapeutic testing ; volume:1 ; number:1 ; day:20 ; month:12 ; year:2019 ; pages:1-18 ; date:12.2019
BMC biomedical engineering ; 1, Heft 1 (20.12.2019), 1-18, 12.2019
- Creator
-
Ornell, Kimberly J.
Coburn, Jeannine M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s42490-019-0034-8
- URN
-
urn:nbn:de:101:1-2020061120285925074617
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ornell, Kimberly J.
- Coburn, Jeannine M.
- SpringerLink (Online service)
Other Objects (12)
Patient-derived xenografts as preclinical neuroblastoma models
Progressive neuroblastoma : innovation and novel therapeutic strategies
Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
FGFR1 is a potential therapeutic target in neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
GPS driving: a digital biomarker for preclinical Alzheimer disease
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives
Epithelial to Mesenchymal Transition in Neuroblastoma: Mechanisms and Therapeutic Considerations
Patient-derived xenografts as preclinical neuroblastoma models
Progressive neuroblastoma : innovation and novel therapeutic strategies
Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
FGFR1 is a potential therapeutic target in neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
GPS driving: a digital biomarker for preclinical Alzheimer disease
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives
Epithelial to Mesenchymal Transition in Neuroblastoma: Mechanisms and Therapeutic Considerations
Patient-derived xenografts as preclinical neuroblastoma models
Progressive neuroblastoma : innovation and novel therapeutic strategies
Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
FGFR1 is a potential therapeutic target in neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
GPS driving: a digital biomarker for preclinical Alzheimer disease
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Prognostic and therapeutic relevance of TERT activation in neuroblastoma
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives